Published : Aug-2017
No. of Pages : 86
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vascular Grafts Overview 7
3 Products under Development 8
3.1 Vascular Grafts - Pipeline Products by Stage of Development 8
3.2 Vascular Grafts - Pipeline Products by Segment 9
3.3 Vascular Grafts - Pipeline Products by Territory 10
3.4 Vascular Grafts - Pipeline Products by Regulatory Path 11
3.5 Vascular Grafts - Pipeline Products by Estimated Approval Date 12
3.6 Vascular Grafts - Ongoing Clinical Trials 13
4 Vascular Grafts - Pipeline Products under Development by Companies 14
4.1 Vascular Grafts Companies - Pipeline Products by Stage of Development 14
4.2 Vascular Grafts - Pipeline Products by Stage of Development 16
5 Vascular Grafts Companies and Product Overview 17
5.1 3S BioMedical, Inc. Company Overview 17
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Ariste Medical LLC Company Overview 19
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 C. R. Bard Inc Company Overview 20
5.3.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Cardiojustable LLC (Inactive) Company Overview 24
5.4.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Colorado Therapeutics, LLC Company Overview 25
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 CryoLife Inc Company Overview 26
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 DSM Biomedical BV Company Overview 27
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Eqalix Inc Company Overview 28
5.8.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 FIT Biotech Oy Company Overview 30
5.9.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Gel-Del Technologies, Inc. Company Overview 32
5.10.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Graftworx, LLC Company Overview 33
5.11.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Healionics Corporation Company Overview 34
5.12.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Humacyte Inc Company Overview 35
5.13.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Innovia LLC Company Overview 39
5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 Northwestern University Company Overview 40
5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 NuVascular Technologies Inc Company Overview 41
5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 PetVivo Holdings Inc Company Overview 42
5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 RegenaGraft Company Overview 43
5.18.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 44
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 SurgaColl Technologies Ltd Company Overview 45
5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Universidad de Los Andes Company Overview 46
5.21.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 University of Louisville Company Overview 47
5.22.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Vascutek Ltd Company Overview 48
5.23.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 VesselTek BioMedical LLC Company Overview 49
5.24.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 VESSL Therapeutics Ltd Company Overview 51
5.25.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
5.26 Xeltis AG Company Overview 52
5.26.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
6 Vascular Grafts- Recent Developments 53
6.1 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 53
6.2 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 53
6.3 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 55
6.4 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 56
6.5 Jul 07, 2017: MPSC New COO Glendy Wang on Board 57
6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 57
6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 59
6.8 Apr 27, 2017: Fit Biotech: Appointments in Fit Biotech's Management 60
6.9 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 61
6.10 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 61
6.11 Apr 23, 2017: Bard Announces First Quarter Results 62
6.12 Apr 03, 2017: Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access 63
6.13 Mar 30, 2017: FIT Biotech: Appointment to FIT Biotech's Management Team 63
6.14 Mar 30, 2017: MPSC Announces 2016 Annual Results 64
6.15 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 66
6.16 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 66
6.17 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67
6.18 Jan 26, 2017: Bard Announces Fourth Quarter Results 68
6.19 Jan 16, 2017: SurgaColl Technologies: Board Announcement - Appointment of CEO 69
6.20 Dec 29, 2016: Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial 69
6.21 Nov 03, 2016: DSM Q3 2016 Results 70
6.22 Nov 01, 2016: Xeltis Announces Multidisciplinary Scientific Advisory Board of Global Leading Experts 72
6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 73
6.24 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 75
6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 76
6.26 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 76
6.27 Oct 25, 2016: Bard Announces Third Quarter Results 77
6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 77
6.29 Sep 16, 2016: Federal Circuit Court of Appeals upholds LifeNet Health's $34.7 million patent victory 78
6.30 Sep 14, 2016: Fit Biotech Oy's Half-year Financial Report January 1-June 30, 2016 78
6.31 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 80
6.32 Aug 30, 2016: MPSC Announces 2016 Interim Results 80
7 Appendix 83
7.1 Methodology 83
7.2 About GlobalData 86
7.3 Contact Us 86
7.4 Disclaimer 86
1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Table 2: Vascular Grafts - Pipeline Products by Segment 9
Table 3: Vascular Grafts - Pipeline Products by Territory 10
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
Table 6: Vascular Grafts - Ongoing Clinical Trials 13
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 14
Table 8: Vascular Grafts - Pipeline Products by Stage of Development 16
Table 9: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status 17
Table 11: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description 17
Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Status 18
Table 13: Resorpor AdvaMatrixrPro Vessel Graft - Product Description 18
Table 14: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 15: Drug Eluting Vascular Graft - Product Status 19
Table 16: Drug Eluting Vascular Graft - Product Description 19
Table 17: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Covera Vascular Covered Stent Graft - Product Status 20
Table 19: Covera Vascular Covered Stent Graft - Product Description 21
Table 20: Lifestream Stent Graft - Product Status 21
Table 21: Lifestream Stent Graft - Product Description 21
Table 22: C. R. Bard Inc - Ongoing Clinical Trials Overview 22
Table 23: Lifestream Stent Graft - A Prospective, Multi-center, Non-randomized, Single-arm Study of the Bard Lifestream Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: BOLSTER 23
Table 24: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Adjustable SPA Shunt - Product Status 24
Table 26: Adjustable SPA Shunt - Product Description 24
Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
Table 33: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: Small Diameter Vascular Graft - Product Status 27
Table 35: Small Diameter Vascular Graft - Product Description 27
Table 36: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: CardioVessel - Product Status 28
Table 38: CardioVessel - Product Description 28
Table 39: LCL Graft - Product Status 29
Table 40: LCL Graft - Product Description 29
Table 41: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: GTU X-Graft - Product Status 30
Table 43: GTU X-Graft - Product Description 30
Table 44: GTU X2-Graft - Product Status 31
Table 45: GTU X2-Graft - Product Description 31
Table 46: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 47: VasoGraft - Product Status 32
Table 48: VasoGraft - Product Description 32
Table 49: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 50: Smart Graft - Product Status 33
Table 51: Smart Graft - Product Description 33
Table 52: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
Table 53: STARgraft - Vascular Reconstruction - Product Status 34
Table 54: STARgraft - Vascular Reconstruction - Product Description 34
Table 55: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 56: HAV Graft - Vascular Trauma - Product Status 35
Table 57: HAV Graft - Vascular Trauma - Product Description 35
Table 58: HUMACYL - Peripheral Artery Disease - Product Status 36
Table 59: HUMACYL - Peripheral Artery Disease - Product Description 36
Table 60: Humacyte Inc - Ongoing Clinical Trials Overview 37
Table 61: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma 38
Table 62: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 63: 4mm Vascular Graft - Product Status 39
Table 64: 4mm Vascular Graft - Product Description 39
Table 65: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Status 40
Table 67: ePTFE Graft - Peripheral Arterial Disease - Product Description 40
Table 68: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 69: BioFunc - APC Vascular Graft - Product Status 41
Table 70: BioFunc - APC Vascular Graft - Product Description 41
Table 71: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 72: Peripheral Vascular Graft - Product Status 42
Table 73: Peripheral Vascular Graft - Product Description 42
Table 74: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
Table 75: RegenaVasc - Product Status 43
Table 76: RegenaVasc - Product Description 43
Table 77: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
Table 78: Enhanced Vascular Graft - Product Status 44
Table 79: Enhanced Vascular Graft - Product Description 44
Table 80: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Table 81: CardioColl - Product Status 45
Table 82: CardioColl - Product Description 45
Table 83: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
Table 84: SiSgraft - Product Status 46
Table 85: SiSgraft - Product Description 46
Table 86: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
Table 87: Vascular Graft System - Product Status 47
Table 88: Vascular Graft System - Product Description 47
Table 89: Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 90: Triplex Advanced Vascular Graft - Product Status 48
Table 91: Triplex Advanced Vascular Graft - Product Description 48
Table 92: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 93: VTek Graft - Product Status 49
Table 94: VTek Graft - Product Description 49
Table 95: VTek-RA Wrap - Product Status 50
Table 96: VTek-RA Wrap - Product Description 50
Table 97: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 98: MultiGeneGraft - Product Status 51
Table 99: MultiGeneGraft - Product Description 51
Table 100: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
Table 101: Endogenous Tissue Growth Implant - Product Status 52
Table 102: Endogenous Tissue Growth Implant - Product Description 52
Table 103: Glossary 85
1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Figure 2: Vascular Grafts - Pipeline Products by Segment 9
Figure 3: Vascular Grafts - Pipeline Products by Territory 10
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
Figure 6: Vascular Grafts - Ongoing Clinical Trials 13
